BillionToOne Reports Over 100% Growth in Revenue Year-Over-Year | PR Newswire [Video]

Company Announces Record Financial Results at 43rd Annual J.P. Morgan Healthcare Conference

MENLO PARK, Calif., Jan. 28, 2025 /PRNewswire/ — BillionToOne, a next-generation molecular diagnostics company, announced record financial results at this year’s J.P. Morgan Healthcare Conference in San Francisco. In 2024, the company’s revenue reached $153 million, more than doubling from $72 million in 2023.

BillionToOne’s success has been driven primarily by its prenatal testing business, which has captured an estimated 15% market share in the U.S.

“We saw strong momentum in our prenatal business during 2024, with tremendous revenue growth and profitability in the fourth quarter,” said Dr. Oguzhan Atay, Co-founder and CEO of BillionToOne. “We have achieved robust prenatal business growth with a fraction of the sales force size of our largest competitor, demonstrating the power of our technology and differentiation that our products have.”

Building on its success in prenatal testing, BillionToOne is now accelerating its expansion into …